ONPH (Oncology Pharma) Market Cap: $2.01 Mil (As of Jun. 27, 2026)


What is Oncology Pharma Market Cap?

Oncology Pharma ONPH -24.29% Market Cap is $2.01 Mil as of Jun. 27, 2026.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Oncology Pharma's share price for the quarter that ended in Dec. 2004 was $0. Oncology Pharma's Shares Outstanding (EOP) for the quarter that ended in Dec. 2004 was 1.16 Mil. Therefore, Oncology Pharma's market cap for the quarter that ended in Dec. 2004 was $0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Oncology Pharma's Enterprise Value for Today is $0.00 Mil.

Oncology Pharma  (OTCPK:ONPH) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Oncology Pharma Market Cap Related Terms

Oncology Pharma Market Cap Historical Data

* Premium members only.

The historical data trend for Oncology Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncology Pharma Market Cap Chart

Oncology Pharma Annual Data
Trend Jun96 Jun97 Jun98 Mar00 Mar01 Mar02 Mar03
Market Cap
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Oncology Pharma Quarterly Data
Mar00 Jun00 Sep00 Dec00 Mar01 Jun01 Sep01 Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ONPH vs TAUG, IMUN, TNTY: Market Cap Comparison

For the Shell Companies subindustry, Oncology Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncology Pharma Market Cap vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Oncology Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Oncology Pharma's Market Cap falls into.


Oncology Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Oncology Pharma's Market Cap for the fiscal year that ended in Mar. 2003 is calculated as

Market Cap (A: Mar. 2003 )=Share Price (A: Mar. 2003 )*Shares Outstanding (EOP) (A: Mar. 2003 )
=$0*1.164
=$

Oncology Pharma's Market Cap for the quarter that ended in Dec. 2004 is calculated as

Market Cap (Q: Dec. 2004 )=Share Price (Q: Dec. 2004 )*Shares Outstanding (EOP) (Q: Dec. 2004 )
=$0*1.164
=$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $2.01 Mil mean?
Oncology Pharma (ONPH) has a Market Cap of $2.01 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Oncology Pharma and its competitors.
Is Oncology Pharma's Market Cap too high?
Oncology Pharma's current Market Cap is $2.01 Mil. The Diversified Financial Services industry median Market Cap is 84.50. Oncology Pharma's value of $2.01 Mil is 97.6% below this industry median.
How does Oncology Pharma's Market Cap compare to TAUG and IMUN?
Oncology Pharma's Market Cap of $2.01 Mil can be compared against companies in the Diversified Financial Services industry. The industry median Market Cap is 84.50. Oncology Pharma's value of $2.01 Mil is 97.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Diversified Financial Services company?
The median Market Cap among Diversified Financial Services companies is 84.50, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oncology Pharma's current Market Cap of $2.01 Mil is 97.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Oncology Pharma and its competitors. For the Diversified Financial Services industry, the median Market Cap is 84.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oncology Pharma's current Market Cap is $2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncology Pharma stock overvalued right now?
Oncology Pharma (ONPH) has a current Market Cap of $2.01 Mil. The current Market Cap is $2.01 Mil and 97.6% below the Diversified Financial Services industry median of 84.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Oncology Pharma (ONPH), the current Market Cap is $2.01 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oncology Pharma Business Description

Address 732 S 6TH Street, Suite R, Las Vegas, NV, USA, 89101
Oncology Pharma Inc is a shell company and currently has no operations.